2013 Annual Meeting | Dementia Update

Date Sunday 03/17/13

Time 10:00 AM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Bradley F. Boeve, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnosis of dementia; recognize the clinical features and practical approaches of the different dementias; understand the basis for amyloid and/or tau as a therapeutic target in Alzheimer's disease; the molecular basis of different dementias; and the genetic components of the dementias.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
10:00 AM - 10:45 AM		Clinical Perspectives on MCI and Alzheimer's Disease Ronald C. Petersen, MD, PhD, FAAN
10:45 AM - 11:30 AM		Biology and Genetics of Dementia Peter H. St George-Hyslop, MD, PhD
11:30 AM - 12:15 PM		Frontotemporal Dementia Bruce L. Miller, MD, FAAN
12:15 PM - 12:30 PM		Questions and Answers
12:30 PM - 01:45 PM		Lunch
01:45 PM - 02:30 PM		Vascular Cognitive Impairment Charles S. DeCarli, MD, FAAN
02:30 PM - 03:15 PM		Parkinsonian-Related Disorders Bradley F. Boeve, MD, FAAN
03:15 PM - 03:30 PM		Break
03:30 PM - 04:15 PM		Acute and Subacute Dementias Michael D. Geschwind, MD, PhD, FAAN
04:15 PM - 05:00 PM		Pathology of Dementias Dennis W. Dickson, MD
05:00 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Peter H. St George-Hyslop, MD, PhD	Dr. St George-Hyslop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TransitionBio. The institution of Dr. St George-Hyslop has received research support from NIH. Dr. St George-Hyslop has received intellectual property interests from a discovery or technology relating to health care.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH.

��ɫ��

��ɫ��